Please contact us for product demonstrations and to learn how your clinical work can benefit most from using our products. Having our roots deep in science, we also strive to provide active support for clinical research.
OxyPrem AG is currently open for both non-dilutive and dilutive funding. The application of funds includes regulatory approvals, production of commercial goods, and extensions of our field of activities.
If you would like to know more about brain oxygen monitoring for newborns, we are always there to answer your questions. We have short and active communication lines to clinical experts, and we are happy to offer our help.
OxyPrem is open to engage in collaborations with the medical device industry, commercial organisations, and other strategic partners. This may involve extending or upgrading of existing partner product lines.